Sign In
test

Harold Schaaff

Soleus Capital Management, L.p.

Assets Managed
$2.469B
Holdings
93
Last Quarter
2026 - Q1
Filed Date
3d ago
Growth Rate
-8.91%(2Q avg: 13.78%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.469B in assets, with a quarterly growth rate of -8.91% and a 2-quarter average growth rate of 13.78%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
KRYS
Krystal Biotech Inc
Recent Activity
Increased 22.54%
12.07%
$297.865M
1.153M shares@ $258.33 avg price
CELC
Celcuity Inc
Recent Activity
Decreased -28.97%
5.94%
$146.599M
1.284M shares@ $114.15 avg price
TGTX
Tg Therapeutics Inc
Recent Activity
Increased 28.36%
5.43%
$133.854M
4.029M shares@ $33.22 avg price
PODD
Insulet Corp
Recent Activity
Increased 275%
4.79%
$118.035M
562,500 shares@ $209.84 avg price
NVCR
Novocure Ltd
Recent Activity
Increased 23%
4.64%
$114.367M
10.492M shares@ $10.91 avg price
UTHR
United Therapeutics Corp
Recent Activity
Increased 211.98%
4.5%
$110.998M
187,187 shares@ $592.98 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
Decreased -8.93%
4.32%
$106.489M
330,517 shares@ $322.19 avg price
VCEL
Vericel Corp
Recent Activity
Increased 233.65%
3.33%
$82.004M
2.549M shares@ $32.17 avg price
ALKS
Alkermes Plc
Recent Activity
Increased 49.05%
2.83%
$69.69M
1.971M shares@ $35.36 avg price
ANIP
Ani Pharmaceuticals Inc
Recent Activity
Increased 68.69%
2.56%
$63.077M
820,243 shares@ $76.91 avg price

1-10 of 93